A randomized controlled trial of a decision aid for women at increased risk of ovarian cancer

Medical Decision Making

Volumn 26, Issue 4, 2006, Pages 360-372

  Tiller, K ^a,b,c   Meiser, B ^a,c   Gaff, C ^d,e   Kirk, J ^f   Dudding, T ^g   Phillips, K A ^h   Friedlander, M ^a,c   Tucker, K ^a,b,c  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b MACQUARIE UNIVERSITY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d Genetic Health Services Victoria   (Australia)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

^f WESTMEAD HOSPITAL   (Australia)

^g UNIVERSITY OF NEWCASTLE   (Australia)

^h PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Decision aid; Hereditary ovarian cancer; Randomized controlled trial; Risk management

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION AID; DECISION MAKING; DISTRESS SYNDROME; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; RANDOMIZED CONTROLLED TRIAL; RISK MANAGEMENT; SCIENTIFIC LITERATURE;

ANXIETY; DECISION MAKING; DECISION SUPPORT TECHNIQUES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PAMPHLETS; PATIENT EDUCATION; PATIENT EDUCATION AS TOPIC; PATIENT SATISFACTION;

EID: 33745918665     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X06290486     Document Type: Article

References (62)

1. Schildkraut JM, Thompson WD. Familial ovarian cancer: a population-based case-control study. Am J Epidemiol. 1988;128:456-66.
2. Fishman D, Cohen L. Is transvaginal ultrasound effective for screening asymptomatic women for the detection of early-stage epithelial ovarian cancer? Gynecol Oncol. 2000;77:347-9.
3. Burke W, Daly M, Garber J, et al. Recommendations for followup care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. JAMA. 1997;277(12):997-1003.
4. National Health and Medical Research Council of Australia. Familial Aspects of Cancer: A Guide to Clinical Practice. Clinical Practice Guidelines. Canberra: Australian Cancer Network; 1999.
5. Kauff N, Satagopan J, Robson M, et al. Risk-reducing salpingooophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2002;346(21):1609-15.
6. Rebbeck T, Lynch H, Neuhausen S, et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med. 2002;346(21):1616-22.
7. Vasen HF. Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. Eur J Cancer. 1998;34(12):1922-6.
8. Anthill Y, Phillips KA. Screening for ovarian cancer high risk. In: Gershenson D, McGuire WP, Gore M, Quinn MA, Thomas G, eds. Gynecologic Cancer: Controversies in Management. Philadelphia: Elsevier; 2004. pp. 341-54.
9. Edwards A, Elwyn G. The potential benefits of decision aids in clinical medicine. JAMA. 1999;282(8):779-80.
10. Frosch D, Kaplan R. Shared decision making in clinical medicine: past research and future directions. Am J Prev Med. 1999;17(4):285-94.
11. O'Connor A. Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications. J Natl Cancer Inst. 1999;25:67-80.
12. Ubel P. Is information always a good thing? Helping patients make 'good' decisions. Med Care. 2002;40(9 Suppl):V39-44.
13. O'Connor A, Rostom A, Fiset V, et al. Decision aids for patients facing health treatment or screening decisions: systematic review. BMJ. 1999:731-4.
14. O'Connor A, Rostom A, Fiset V, et al. Decision aids for people facing health treatment or screening decisions (Cochrane review). Cochrane Database of Systematic Reviews. (3):CD001431 2001(3).
15. Tiller K, Meiser B, Reeson E, et al. A decision aid for women at increased risk for ovarian cancer. Int J Gynecol Cancer. 2003;13:1-8.
16. National Health and Medical Research Council. How to Present Evidence for Consumers: Preparation of Consumer Publications. Canberra, Australia: National Health and Medical Research Council; 1999.
17. O'Connor A. Evaluation standards for patient decision supports. Med Decis Making. 1995;15(1):2-3.
18. O'Connor AM, Tugwell P, Wells GA, et al. A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. Pat Educ Counsel. 1998;33:267-79.
19. O'Connor A, Tugwell P, Welles GA, et al. Randomized trial of a portable, self-administered decision aid for postmenopausal women considering long-term preventative hormone replacement therapy. Med Decis Making. 1998;18:295-303.
20. O'Connor A, Pennie RA, Dales RE. Framing effects on expectations, decisions and side-effects experienced: the case of influenza immunization. J Clin Epidemiol. 1996;49(11):1271-6.
21. O'Connor A, Tugwell P, Welles GA, et al. Guiding the Development of Decision Aids for Patients and Practitioners Considering Health Care Interventions. Ottawa: Ottawa Health Research Institute; 2001. Available from: www.ohri.ca.
22. Tiller K, Meiser B, Reeson L, et al. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer. Psycho-Oncol. 2004;13:1-13.
23. Meiser B, Tiller K, Gleeson M, Andrews L, Robertson G, Tucker K. Psychological impact of prophylactic oophorectomy in women at risk for hereditary ovarian cancer. Psycho-Oncol. 2000;9:496-503.
24. Horowitz MJ, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med. 1979;41:209-18.
25. Meiser B, Butow P, Barratt A, et al. Attitudes to prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer. Gynecol Oncol. 1999;75:122-9.
26. Thewes B, Meiser B, Hickie I. Validation of the Impact of Events Scale in women at increased risk of developing hereditary breast cancer. Psycho-Oncol. 2001;10(6):459-68.
27. Meiser B, Butow P, Barratt A, et al. Attitudes to prophylactic mastectomy in women at increased risk of developing hereditary breast cancer. J Clin Oncol. 2000;18(11):2250-7.
28. Lerman C, Schwartz MD, Lin TH, et al. The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol. 1997;65(3):414-20.
29. Spielberger CD. Manual for the State-Trait Anxiety Inventory for Adults (Form Y). Palo Alto (CA): Mind Garden; 1983.
30. Marteau TM, Bekker H. The development of a six-item short-form of the State scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol. 1992;31:301-6.
31. Zigmond A, Snaith R. The hospital anxiety and depression scale. Psychiatr Scand. 1983;67:361.
32. Hopwood P, Howell A, Maguire P. Screening for psychiatric disorder in patients with advanced breast cancer: validation of two self-report questionnaires. Br J Cancer. 1991;64:353-6.
33. Bjelland I, Dahl A, Haug T, Neckelmann D. The validity of the Hospital and Anxiety Depression Scale. J Psychosom Res. 2002;52(2):69-77.
34. Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L. Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer. 1994;30A(1):37-40.
35. Barry M. Health decision aids to facilitate shared decision making in office practice. Ann Intern Med. 2002;136:127-35.
36. O'Connor A. Validation of a decisional conflict scale. Med Decis Making. 1995;15:25-30.
37. Bunn H, O'Connor A. Validation of client decision-making instruments in the context of psychiatry. Can J Nurs Res. 1996;28(3):13-27.
38. Drake E, Engler-Todd L, O'Connor A, Surh L, Hunter A. Development and evaluation of a decision aid about prenatal testing for women of advanced maternal age. J Genet Counsel. 1999;8(4):217-33.
39. Rothert M, Holmes-Rovner M, Rovner D, et al. An educational intervention as decision support for menopausal women. Res Nurs Health. 1997;377-87.
40. Goldstein H. Multilevel Statistical Models. New York: Halstead; 1995.
41. Mills M, Sullivan K. The importance of information giving for patients newly diagnosed with cancer: a review of the literature. J Clin Nurs. 1999;8:631-42.
42. Jefford M, Tattersall M. Informing and involving cancer patients in their own care. Lancet Oncol. 2002;3:629-37.
43. Molenaar S, Mirjam A, Sprangers G, et al. Feasibility and effects of decision aids. Med Decis Making. 2000(20):112-27.
44. Whelan T, Gafni A, Charles C, Levine M. Lessons learned from the decision board: a unique and evolving decision aid. Health Expect. 2000;3(1):69-79.
45. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med. 1997;44(5):681-92.
46. Fischhoff B. What do patients want? Help in making effective choices. Effect Clin Pract. 1999;2(4):198-200.
47. Fisher R, Fisher E. What is a good decision? Effect Clin Pract. 1999;2(4):189-90.
48. Pauker SG, Pauker SP. What is a good decision? Effect Clin Pract. 1999;2(4):194-6.
49. Rimer B. What is a good decision? Effect Clin Pract. 1999;2(4):193-4.
50. Sox HC. What is a good decision? Effect Clin Pract. 1999;2(4):196-7.
51. Miller SM, Rodoletz M, Schroeder CM, Mangan CE, Sedlacek TV. Applications of the monitoring process model to coping with severe long-term medical threats. Health Psychol. 1996;15(3):216-25.
52. Miller SM, Fang CY, Manne SL, Engstrom PF, Daly MB. Decision making about prophylactic oophorectomy among at-risk women: Psychological influences and implications. Gynecol Oncol. 1999;75:406-12.
53. Leydon G, Boulton M, Moynihan C, et al. Cancer patients' information needs and information seeking behaviour: in depth interview study. BMJ. 2000;320(7239):909-13.
54. Fallowfield LJ, Baum M, Maguire GP. Effects of breast conservation on psychological morbidity associated with diagnosis and treatment of early breast cancer. BMJ. 1986;293:1331-4.
55. Fallowfield LJ, Hall A, Maguire GP, Baum M. Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. BMJ. 1990;301:575-80.
56. Fallowfield L, Ford S, Lewis S. No news is not good news: Information preferences of patients with cancer. Psycho-Oncol. 1995;4:197-202.
57. Lodder LN, Frets P, Trijsburg R, et al. Psychological impact of receiving a BRCA1/BRCA2 test result. Am J Med Genet. 2001;98:15-24.
58. Watson M, Foster C, Evans G. Predictive genetic testing: psychosocial impact of the new genetic technology. Presented at the International Meeting on Psychosocial Aspects of Genetic Testing for Hereditary Breast and/or Ovarian Cancer (HBOC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC), 2001, Frankfurt.
59. Meiser B, Butow P, Friedlander M, et al. Psychological impact of genetic testing for women for breast cancer susceptibility. Eur J Cancer. 2002;38(15):2025-33.
60. Davison B, Kirk P, Degner L, Hassard T. Information and patient participation in screening for prostate cancer. Pat Educ Counsel. 1999;37:255-63.
61. Meiser B, Butow P, Barratt A, et al. Risk perceptions and knowledge of breast cancer genetics in women at increased risk of developing hereditary breast cancer. Psychol Health. 2001;5(4):377-88.
62. Cull A, Anderson EDC, Campbell S, Mackay J, Smyth E, Steel M. The impact of genetic counselling about breast cancer risk on women's risk perceptions and levels of distress. Br J Cancer. 1999;79(3/4):501-8.